← Open Payments lookup

DANIELA GANESCU: Open Payments

NPI 1669572228 · TRENTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$956 in 53 payments from 9 companies in 2025. Trend: 2023 $483 · 2024 $902 · 2025 $956

Food & beverage: $956
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.11$231
Alkermes, Inc.9$161
Teva Pharmaceuticals USA, Inc.10$156
E.R. Squibb & Sons, L.L.C.7$125
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$99
Otsuka America Pharmaceutical, Inc.5$83
Janssen Pharmaceuticals, Inc3$49
ABBVIE INC.2$34
Vanda Pharmaceuticals Inc.1$17

Products named: INGREZZA, UZEDY, ARISTADA, COBENFY, CAPLYTA, ABILIFY MAINTENA, INVEGA SUSTENNA, VRAYLAR.

Industry payments across NJ — which companies pay providers there.